全文获取类型
收费全文 | 165445篇 |
免费 | 11563篇 |
国内免费 | 634篇 |
专业分类
耳鼻咽喉 | 1815篇 |
儿科学 | 4079篇 |
妇产科学 | 2797篇 |
基础医学 | 21798篇 |
口腔科学 | 3540篇 |
临床医学 | 16294篇 |
内科学 | 34968篇 |
皮肤病学 | 3305篇 |
神经病学 | 15294篇 |
特种医学 | 7137篇 |
外国民族医学 | 14篇 |
外科学 | 26034篇 |
综合类 | 2027篇 |
一般理论 | 117篇 |
预防医学 | 12740篇 |
眼科学 | 3568篇 |
药学 | 10763篇 |
中国医学 | 241篇 |
肿瘤学 | 11111篇 |
出版年
2023年 | 952篇 |
2022年 | 1567篇 |
2021年 | 3539篇 |
2020年 | 2179篇 |
2019年 | 3295篇 |
2018年 | 3821篇 |
2017年 | 2938篇 |
2016年 | 3300篇 |
2015年 | 3747篇 |
2014年 | 5339篇 |
2013年 | 7211篇 |
2012年 | 10903篇 |
2011年 | 11672篇 |
2010年 | 6622篇 |
2009年 | 6331篇 |
2008年 | 10243篇 |
2007年 | 10713篇 |
2006年 | 10578篇 |
2005年 | 10626篇 |
2004年 | 9730篇 |
2003年 | 8947篇 |
2002年 | 8569篇 |
2001年 | 2222篇 |
2000年 | 1889篇 |
1999年 | 2194篇 |
1998年 | 1985篇 |
1997年 | 1606篇 |
1996年 | 1368篇 |
1995年 | 1282篇 |
1994年 | 1153篇 |
1993年 | 1049篇 |
1992年 | 1322篇 |
1991年 | 1202篇 |
1990年 | 1042篇 |
1989年 | 980篇 |
1988年 | 919篇 |
1987年 | 900篇 |
1986年 | 894篇 |
1985年 | 869篇 |
1984年 | 929篇 |
1983年 | 801篇 |
1982年 | 974篇 |
1981年 | 873篇 |
1980年 | 734篇 |
1979年 | 660篇 |
1978年 | 655篇 |
1977年 | 539篇 |
1976年 | 519篇 |
1974年 | 514篇 |
1973年 | 449篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
Thomas J. Cahill Shehan Hettiaratchy Alex Clarke Peter E.M. Butler 《Transplantation reviews (Orlando, Fla.)》2006,20(2):76-81
Animal models have traditionally provided the basis for preliminary investigation of new techniques prior to trials taking place in human subjects. The timing of when to proceed with human trials is difficult, as the accuracy of preclinical models can only be determined with hindsight. This review outlines the progression from transplantation in animal models to man. Now that many transplant procedures are well established, it is possible to assess the predictive value and limitations of animal models. These results are of great importance in the current debate about composite tissue allotransplantation (CTA) and in particular facial transplantation. This progression of CTA from animal models to man is outlined and compared with early renal, cardiac, and liver transplants. There is some evidence to suggest that animal models may have been misleading in CTA and that this has effectively delayed the transition to humans. The role for animal models in facial transplantation, which is currently making the step to clinical trials, is discussed. 相似文献
92.
This article describes the proceedings of the 2006 Annual Meeting of the Fetal Alcohol Spectrum Disorders Study Group (FASDSG), which was held in Baltimore, Maryland on June 24, 2006. The meeting was held in conjunction with the annual meeting of the Research Society on Alcoholism and was supported by a grant from the National Institute on Alcohol Abuse and Alcoholism. The 2005-2006 FASDSG officers, Daniel J. Bonthius (President), Heather Carmichael Olson (Vice-President), and Jennifer Thomas (Secretary-Treasurer), organized the meeting. Nationally prominent speakers delivered plenary lectures on topics of newborn screening, ethics, and neuroscience. Selected members of the FASDSG provided brief scientific data (FASt) reports, describing new research findings. Representatives from national agencies involved in fetal alcohol syndrome (FAS) research, treatment, and prevention provided updates regarding priorities, funding, and agency activities. Presentations were also made by the 2006 Student Merit Award recipient and by the 2006 Rosett Award recipient. The meeting served as a forum for clinicians, neuroscientists, psychologists, social scientists, and other professionals to discuss recent advances in FAS research and to identify the most important gaps in the understanding of alcohol-induced teratology. 相似文献
93.
Socioeconomic determinants of health related quality of life in childhood and adolescence: results from a European study . von Rueden , U. , Gosch , A. , Rajmil , L. , Bisegger , C. , Ravens-Sieberer , U. , the European KIDSCREEN group ( 2006 ) Journal of Epidemiology and Community Health , 60 , 130 – 135 . 相似文献
94.
Outcomes at 3 years of a prospective pilot study of Campath-1H and sirolimus immunosuppression for renal transplantation 总被引:2,自引:0,他引:2
Rolf N. Barth Christina A. Janus Christine A. Lillesand Nancy A. Radke John D. Pirsch Bryan N. Becker Luis A. Fernandez L. Thomas Chin Yolanda T. Becker Jon S. Odorico Anthony M. D''Alessandro Hans W. Sollinger Stuart J. Knechtle 《Transplant international》2006,19(11):885-892
Campath-1H (alemtuzumab) induction was used for renal transplantation in combination with sirolimus as immunosuppression. We previously reported a high (28%) rate of early rejection with this regimen, and now report 3-year outcomes. Twenty-nine patients were recipients of either deceased donor or non-HLA (Human Leukocyte Antigen) identical living donor primary renal allografts. Clinical parameters including infection, malignancy, kidney function, and kidney histology were followed prospectively for 3 years. Three-year cumulative graft and patient survival were 96% and 100%, respectively. Twenty patients were maintained on steroid-free immunosuppressive regimens, and 15 patients were maintained on monotherapy for immunosuppression (12 on sirolimus). No serious infectious complications were observed and two patients developed basal cell skin cancer. The 3-year results of our initial pilot study demonstrate good graft (96%) and patient (100%) outcomes. Campath-1H induction has yielded a high proportion of patients maintained on immunosuppressive monotherapy (57%) without serious infectious- and no malignancy-related complications. The reported regimen yielded novel insights into both Campath-1H and sirolimus therapy in renal transplantation. Because of the higher incidence of early rejection, we recommend a modified strategy of immunosuppression including a brief course of a calcineurin inhibitor. 相似文献
95.
96.
97.
98.
Human and mouse genomes contain more than 20 related genes encoding diverse type I interferons (IFNs- alpha/beta), cytokines that are crucial for resistance of organisms against viral infections. Although the amino acid sequences of various IFN-alpha/beta subtypes differ markedly, they are all considered to share a common three-dimensional structure and to bind the same heterodimeric receptor, composed of the IFNAR-1 and IFNAR-2 subunits. Analysis of available mammalian IFN-beta sequences showed that they all carry 1 to 5 predicted N-glycosylation sites. Murine IFN-beta contains three predicted N-glycosylation sites (Asn29, Asn69, Asn76), one of which (Asn29) is located in the AB loop, in a region predicted to interact with the type I IFN receptor. The aim of this work was to test if this site is indeed N-glycosylated and if this glycosylation would affect IFN antiviral activity. We showed that all three N-glycosylation sites predicted from the sequence, including Asn29, carry N-linked sugars. Mutation of individual N-glycosylation sites had a weak negative influence on IFN antiviral activity. In contrast, the complete loss of glycosylation dramatically decreased activity. Our data suggest that interaction of murine IFN-beta with the IFNAR could locally differ from that of human IFN-alpha2 and human IFN-beta. 相似文献
99.
100.
Andrea R Genazzani Hermann P G Schneider Nick Panay Esme A Nijland 《Gynecological endocrinology》2006,22(7):369-375
OBJECTIVES: To identify and describe current women's thoughts about the menopause, hormone treatment (HT) and perceptions about breast cancer. METHODS: Between December 2004 and January 2005, 4201 postmenopausal women in seven European countries were interviewed via a standardized computer-aided telephone interview protocol. RESULTS: Almost all women reported to have experienced climacteric symptoms, and 63% of the women rated them as being severe. Only 52% of women were aware of the benefits of HT for relief of climacteric symptoms. Although 84% felt that severe symptoms should be treated, only 40% had used HT at some point in time. Thirty-four percent of the women preferring treatment with natural products did so because of the risk of breast cancer associated with HT. HT was recognized by 59% of the women as one of the most important contributors to an increased breast cancer risk. Most women received their information about HT and breast cancer risk from the media. CONCLUSIONS: This European survey reveals that the majority of women experience climacteric symptoms but that their decision whether or not to use HT is highly dependent on their concern about breast cancer risk. An increase in knowledge of the benefits and risks of HT is required for women to make appropriate decisions about hormone use. 相似文献